Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications

Read more

Agreement to buy F-Star Alpha between Bristol-Myers Squibb and F-star Alpha terminated

Read more

Sorrento Therapeutics successfully completes acquisition of Virttu Biologics

Read more

Dr. Wilson appointed TAPIMMUNE President after Dr. Bonfiglio’s resignation

Read more

FDA approves Rydapt in combination with Chemotherapy for treatment of AML

Read more

MedMira receives CE Marks on its syphilis/HIV rapid test

Read more

Allergan completes acquisition of ZELTIQ Aesthetic

Read more

enGene appoints Theresa Podrebarac as CMO

Read more

FDA grants Pfizer’s Lorlatinib breakthrough designation for NSCLC

Read more

Takeda, Harrington to advance development of rare disease therapeutics

Read more